| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/26/2007 | EP1282365B1 Preparation for the prevention and/or treatment of vascular disorders |
| 12/26/2007 | EP1265914B1 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 12/26/2007 | EP1261363B1 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS |
| 12/26/2007 | EP1235596B1 Use of lytic toxins and toxin conjugates |
| 12/26/2007 | EP1187634B1 Cell growth inhibition |
| 12/26/2007 | EP1171137B1 Use of triacetyluridine for the treatment of mitochondrial disorders |
| 12/26/2007 | EP0862455B1 Interferon-polymer conjugates and process for preparing the same |
| 12/26/2007 | EP0778848B1 Agents for inducing apoptosis and applications of said agents in therapy |
| 12/26/2007 | CN101094689A Treatment of obesity and related disorders |
| 12/26/2007 | CN101094673A Combination comprising zd6474 and an antiandrogen |
| 12/26/2007 | CN101094671A Combination therapy comprising an adenosine a1 receptor antagonist and an aldosterone inhibitor |
| 12/26/2007 | CN101094663A Anti-itch cloth for women |
| 12/26/2007 | CN101092409A C-aryl glucoside sglt2 inhibitors and method |
| 12/26/2007 | CN101092388A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 12/26/2007 | CN101091795A Prevention and treatment of synucleinopathic disease |
| 12/26/2007 | CN101091708A Composition for reducing blood fat, and preparation method |
| 12/26/2007 | CN101091703A Renin inhibitor-containing synergetic compositions designated for treatment of cardiovascular disease |
| 12/26/2007 | CN100357324C Effectors of innate immunity |
| 12/26/2007 | CN100356979C Integrin expression inhibitors |
| 12/25/2007 | US7312373 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 12/25/2007 | US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders |
| 12/25/2007 | US7312321 Antibody to human enzymes of the metalloprotease family |
| 12/25/2007 | US7312317 P2Y4 antibodies |
| 12/25/2007 | US7312237 Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases |
| 12/25/2007 | US7312231 Quaternization of compound for treatment of urogenital disorders, respiratory system disorders or gastrointestinal disorders |
| 12/25/2007 | US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 12/25/2007 | US7312196 Formulations for amylin agonist peptides |
| 12/25/2007 | US7312078 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 12/25/2007 | US7311928 Topical compositions containing tea tree oil for treatment of viral lesions |
| 12/25/2007 | US7311924 Compositions and methods for treating cancer |
| 12/25/2007 | US7311908 Pharmaceutical compositions of fibrinolytic agent |
| 12/21/2007 | WO2007147123A1 Treating psychological conditions using muscarinic receptor m1 antagonists |
| 12/21/2007 | WO2007146983A2 Compositions comprising tegaserod alone or in combination with a proton pump inhibitor for treating or preventing gastric injury |
| 12/21/2007 | WO2007146900A2 Antihypertensive therapy method |
| 12/21/2007 | WO2007146684A1 Ophthalmic compositions comprising a branched, glycerol compound and a cationic antimicrobial |
| 12/21/2007 | WO2007146188A2 Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy |
| 12/21/2007 | WO2007145874A1 Anti-nicotine treatment comprising use of three anticholinergic agents |
| 12/21/2007 | WO2007145520A1 Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof |
| 12/21/2007 | WO2007145365A1 Therapeutic agent for cancer and method for screening for the same |
| 12/21/2007 | WO2007145326A1 Method for determination of inflammatory disease |
| 12/21/2007 | WO2007145308A1 Agent for prevention and/or treatment of glomerulopathy |
| 12/21/2007 | WO2007145306A1 Element having long blood-circulating time which is degradable selectively in tumor tissue |
| 12/21/2007 | WO2007145227A1 Hematopoietic stem cell proliferation promoter |
| 12/21/2007 | WO2007144985A1 Use of rpn2 gene expression inhibitor |
| 12/21/2007 | WO2007144501A2 Use of a vasopeptidase inhibitor for the treatment of pulmonary arterial hypertension |
| 12/21/2007 | WO2007144422A2 Combination preparations comprising bifeprunox and l-dopa |
| 12/21/2007 | WO2007144418A1 Oral pharmaceutical composition of a poorly water-soluble active substance |
| 12/21/2007 | WO2007144381A1 Composition for the relief of joint pain |
| 12/21/2007 | WO2007144358A1 Use of adipose-tissue cell fractions for post-irradiation tissue regeneration |
| 12/21/2007 | WO2007144198A2 Fplr-1 inhibitors for use in diseases involving amyloid-induced inflammatory events (flipr and flipr-like) and immunecomplex-mediated diseases |
| 12/21/2007 | WO2007144195A2 Pharmaceutical composition with synergistic anticonvulsant effect |
| 12/21/2007 | WO2007144083A2 Ache-nmda combination wafer |
| 12/21/2007 | WO2007144082A2 Combination antihypertensive wafer |
| 12/21/2007 | WO2007144080A2 Combination antidepressants wafer |
| 12/21/2007 | WO2007089787A3 Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients |
| 12/21/2007 | WO2007079000A3 Kit comprising an osmotic laxative and a stimulant laxative for prepariing the colon for virtual colonoscopy |
| 12/21/2007 | WO2007075555A3 Combination of an h3 antagonist/inverse agonist and an appetite suppressant |
| 12/21/2007 | WO2007047327A3 Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency |
| 12/21/2007 | WO2007026224A3 5-ht1b antagonist composition for depression, anxiety and cognition |
| 12/21/2007 | WO2007006790A3 Combination of a dpp-iv inhibitor and a cannabinoid cb1 receptor antagonist |
| 12/21/2007 | CA2660648A1 Compositions and methods for treating diseases |
| 12/21/2007 | CA2657951A1 Agents for promoting the growth of hematopoietic stem cells |
| 12/21/2007 | CA2655355A1 Use of rpn2 gene expression inhibitor |
| 12/21/2007 | CA2655144A1 Antihypertensive therapy method |
| 12/21/2007 | CA2655131A1 Treating psychological conditions using muscarinic receptor m1 antagonists |
| 12/21/2007 | CA2655019A1 Use of a vasopeptidase inhibitor for the treatment of pulmonary arterial hypertension |
| 12/21/2007 | CA2654557A1 Combination preparations comprising bifeprunox and l-dopa |
| 12/21/2007 | CA2654211A1 Combination antihypertensive wafer |
| 12/21/2007 | CA2654111A1 Oral pharmaceutical composition of a poorly water-soluble active substance |
| 12/21/2007 | CA2654021A1 Use of adipose-tissue cell fractions for post-irradiation tissue regeneration |
| 12/21/2007 | CA2653047A1 Type-2 diabetes combination wafer |
| 12/21/2007 | CA2653030A1 Ache-nmda combination wafer |
| 12/21/2007 | CA2652476A1 Combination antidepressants wafer |
| 12/21/2007 | CA2651679A1 Pharmaceutical composition with synergistic anticonvulsant effect |
| 12/20/2007 | US20070293703 Preparation and purification of synthetic capsaicin |
| 12/20/2007 | US20070293668 Phenylindoles for the treatment of HIV |
| 12/20/2007 | US20070293579 Use of carp inhibitors for the treatment of heart diseases |
| 12/20/2007 | US20070293572 Anti-Fatigue Composition |
| 12/20/2007 | US20070293570 Pharmaceutical uses for alpha2delta ligands |
| 12/20/2007 | US20070293566 Combinations of vanadium with antidiabetics for glucose metabolism disorders |
| 12/20/2007 | US20070293564 Dimeric compounds and their use as anti-viral agents |
| 12/20/2007 | US20070293557 Anticancer compositions, and methods of making and using the same |
| 12/20/2007 | US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 12/20/2007 | US20070293474 Combination of a DPP IV inhibitor and a cardiovascular compound |
| 12/20/2007 | US20070293468 Reacting indazolium hydrochloride with Sodium tetrachlorobisindazoleruthenate(III) to form trans-Indazolium [tetrachlorobisindazoleruthenate(III)] (KP1019), and sodium chloride; both highly effective and water soluble; bioavailability; cancer treatment |
| 12/20/2007 | US20070293453 Combinatorial Methods For Inducing Cancer Cell Death |
| 12/20/2007 | US20070293450 Identification of ses-3 and the uses of same |
| 12/20/2007 | US20070292885 Human cdnas and proteins and uses thereof |
| 12/20/2007 | US20070292530 Topical composition and method for the treatment and prophylaxis of dermal irritations |
| 12/20/2007 | US20070292454 Therapeutic calcium phosphate particles and methods of manufacture and use |
| 12/20/2007 | US20070292430 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 12/20/2007 | US20070292424 Novel human eosinophil-derived basic protein |
| 12/20/2007 | US20070292419 Treatment with anti-erbb2 antibodies |
| 12/20/2007 | US20070292417 Chimeric allgraft tolerance induction, monitoring and maintenance |
| 12/20/2007 | US20070292388 In vitro method wherein mammalian beta-cell differentiation can be induced in dedifferentiated exocrine pancreatic cells in medium comprising ligands of EGF receptor and GP130 receptor, such as EGF and LIF; insulin secreting cells obtainable by this method provide means for treatment of diabetes |
| 12/20/2007 | DE10325813B4 Prophylaxe und/oder Therapie bei der portalen Hypertonie Prophylaxis and / or therapy of portal hypertension in |
| 12/20/2007 | DE102006027795A1 Raucherentwöhnungs-Kombinationswafer Smoking cessation combination wafer |
| 12/20/2007 | DE102006027794A1 Antihypertonie-Kombinationswafer Antihypertensive combination wafer |
| 12/20/2007 | DE102006027793A1 Opioid-Kombinations-Wafer Opioid combination wafer |
| 12/20/2007 | DE102006027792A1 Antidepressiva-Kombinations-Wafer Antidepressants Combination wafer |